John A. Lewicki's Net Worth
$98.3 Thousand
Who is John A. Lewicki?
John A. Lewicki does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Mereo BioPharma Group plc, and OncoMed Pharmaceuticals Inc.
SEC CIK
John A. Lewicki's CIK is 0001553352
Past Insider Trading and Trends
2015 was John A. Lewicki's most active year for acquiring shares with 1 total transactions. John A. Lewicki's most active month to acquire stocks was the month of December. 2014 was John A. Lewicki's most active year for disposing of shares, totalling 2 transactions. John A. Lewicki's most active month to dispose stocks was the month of May. 2024 saw John A. Lewicki paying a total of $0.00 for 137,000 shares, this is the most they've acquired in one year. In 2014 John A. Lewicki cashed out on 4,000 shares for a total of $98,348.11, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Mereo BioPharma Group plc (MREO) Snapshot price: $4.03
Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -33.18% | -24.22K |
$3.49 | -$84,426.87 | 48.78K |
Jun 25 - Jun 26
| |||
Form 4
| +1,723.71% | 69K |
—
|
—
| 73K |
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OncoMed Pharmaceuticals Inc No price found
EVP & Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Scheduled
|
Feb 2
| ||
Form 4/A
| -16.67% | -4.00K |
$24.59 | -$98,348.11 | 20K |
Scheduled
|
Jun 16
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||